During the past decade, VA Western New York Healthcare System, Buffalo, NY conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 33 clinical trials were completed, i.e. on average, 122.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 12 clinical trials were completed. i.e. 171.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "VA Western New York Healthcare System, Buffalo, NY" #1 sponsor was "VA Office of Research and Development" with 22 trials, followed by "US Department of Veterans Affairs" with 12 trials sponsored, "National Cancer Institute (NCI)" with 10 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored and "AbbVie" with 4 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "VA Western New York Healthcare System, Buffalo, NY" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "The VA Western New York Healthcare System" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "VA Western New York Healthcare System, Buffalo, NY" are "Prostate Cancer" (5 trials), "Acute Renal Failure" (3 trials), "COPD" (3 trials), "Clear Cell Renal Cell Carcinoma" (3 trials) and "Stage III Renal Cell Cancer AJCC v7" (3 trials). Many other conditions were trialed in "VA Western New York Healthcare System, Buffalo, NY" in a lesser frequency.

Most popular intervention types in "VA Western New York Healthcare System, Buffalo, NY" are "Drug" (29 trials), "Other" (18 trials), "Behavioral" (15 trials), "Biological" (8 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Bevacizumab" (5 trials), "Placebo" (4 trials), "Cisplatin" (3 trials) and "Docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "VA Western New York Healthcare System, Buffalo, NY" are 60 trials for "All" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "VA Western New York Healthcare System, Buffalo, NY". undefined are not yet recruiting, 5 are recruiting, 13 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 38 completed trials in VA Western New York Healthcare System, Buffalo, NY, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in VA Western New York Healthcare System, Buffalo, NY, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 22 trials that are defined as “Not Applicable".